CN Patent

CN117377765A — 一种核酸配体及其缀合物、其制备方法和用途

Assigned to Shanghai Tuojie Biomedical Technology Co ltd · Expires 2024-01-09 · 2y expired

What this patent protects

一种核酸配体及其缀合物、其制备方法和用途。具体而言，提供了一种配体，其具有如式(I)所示的结构，提供的配体通过与核酸缀合达到了优异的表达抑制效果。

USPTO Abstract

一种核酸配体及其缀合物、其制备方法和用途。具体而言，提供了一种配体，其具有如式(I)所示的结构，提供的配体通过与核酸缀合达到了优异的表达抑制效果。

Drugs covered by this patent

Patent Metadata

Patent number
CN117377765A
Jurisdiction
CN
Classification
—
Expires
2024-01-09
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Tuojie Biomedical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.